HIV antibody therapy is associated with enhanced immune responses in infected individuals

by University of Montreal Hospital Research CentreMicroscopic image of an HIV-infected T cell. Credit: NIAIDMost people living with HIV control the virus thanks to antiretroviral therapy (ART). Althou

Updated on: April 16,2024 13

HIV antibody therapy is associated with enhanced immune responses in infected individuals

by University of Montreal Hospital Research CentreMicroscopic image of an HIV-infected T cell. Credit: NIAIDMost people living with HIV control the virus thanks to antiretroviral therapy (ART). Althou

Updated on:April 16,2024 13

HIV: Reprogramming cells to control infection

by Pasteur InstituteMicroscopic image of an HIV-infected T cell. Credit: NIAIDCells from the rare individuals who naturally control HIV infection have been the focus of investigation for nearly 1

Updated on: April 16,2024 14

HIV: Reprogramming cells to control infection

by Pasteur InstituteMicroscopic image of an HIV-infected T cell. Credit: NIAIDCells from the rare individuals who naturally control HIV infection have been the focus of investigation for nearly 1

Updated on:April 16,2024 14

HIV-infected cells persist in CSF in individuals on long-term ART

(HealthDay)—About half of HIV-positive individuals on long-term antiretroviral therapy (ART) have HIV-infected cells in their cerebrospinal fluid (CSF), according to a study published online July 15 i

Updated on: April 16,2024 13

HIV-infected cells persist in CSF in individuals on long-term ART

(HealthDay)—About half of HIV-positive individuals on long-term antiretroviral therapy (ART) have HIV-infected cells in their cerebrospinal fluid (CSF), according to a study published online July 15 i

Updated on:April 16,2024 13

Type-I interferon stops immune system from 'going rogue' during viral infections

by McMaster UniversityCredit: CC0 Public DomainMcMaster University researchers have found not only how some viral infections cause severe tissue damage, but also how to reduce that damage.They ha

Updated on: April 16,2024 11

Type-I interferon stops immune system from 'going rogue' during viral infections

by McMaster UniversityCredit: CC0 Public DomainMcMaster University researchers have found not only how some viral infections cause severe tissue damage, but also how to reduce that damage.They ha

Updated on:April 16,2024 11

Highly active HIV antibody restricts development of viral resistance

by German Center for Infection Research(left to right): Henning Gruell, Philipp Schommers and Florian Klein. Credit: Uniklinik Koeln/Thies SchoeningAntiretroviral drugs are the gold standard for the t

Updated on: April 16,2024 19

Highly active HIV antibody restricts development of viral resistance

by German Center for Infection Research(left to right): Henning Gruell, Philipp Schommers and Florian Klein. Credit: Uniklinik Koeln/Thies SchoeningAntiretroviral drugs are the gold standard for the t

Updated on:April 16,2024 19

HIV RNA expression inhibitors may restore immune function in HIV-infected individuals

by Boston University School of MedicineHIV infecting a human cell. Credit: NIHImmune activation and inflammation persist in the majority of treated HIV-infected individuals and is associated with

Updated on: April 16,2024 18

HIV RNA expression inhibitors may restore immune function in HIV-infected individuals

by Boston University School of MedicineHIV infecting a human cell. Credit: NIHImmune activation and inflammation persist in the majority of treated HIV-infected individuals and is associated with

Updated on:April 16,2024 18

ISG15 deficiency linked to antiviral immunity in humans

(HealthDay)—Investigators describe a strategy for development of a broad-spectrum anti-viral agent. Their research was published online May 19 inNature Communications.Noting that studies in mice

Updated on: April 16,2024 18

ISG15 deficiency linked to antiviral immunity in humans

(HealthDay)—Investigators describe a strategy for development of a broad-spectrum anti-viral agent. Their research was published online May 19 inNature Communications.Noting that studies in mice

Updated on:April 16,2024 18

HIV: an innovative therapeutic breakthrough to optimize the immune system

by Institut national de la recherche scientifique - INRSINRS Professor Julien vanGrevenynghe, expert in immunology and virology, and doctoral student Hamza Loucif, first author of the paper. Cre

Updated on: April 16,2024 16

HIV: an innovative therapeutic breakthrough to optimize the immune system

by Institut national de la recherche scientifique - INRSINRS Professor Julien vanGrevenynghe, expert in immunology and virology, and doctoral student Hamza Loucif, first author of the paper. Cre

Updated on:April 16,2024 16

IgA antibodies seem to protect unvaccinated against COVID-19

by University of GothenburgT-cell populations that responded to stimulation with SARS-CoV-2 peptides. PBMC from individuals with IgG-dominated, IgA-dominated, and no antibody response to Covid-19

Updated on: April 16,2024 16

IgA antibodies seem to protect unvaccinated against COVID-19

by University of GothenburgT-cell populations that responded to stimulation with SARS-CoV-2 peptides. PBMC from individuals with IgG-dominated, IgA-dominated, and no antibody response to Covid-19

Updated on:April 16,2024 16

Type III interferon in COVID-19: Protective or harmful?

by Children's Hospital BostonCredit: CC0 Public DomainOur immune system makes interferons and other cytokines to help us fight viruses. But in COVID-19, we've learned that they can also c

Updated on: April 16,2024 15

Type III interferon in COVID-19: Protective or harmful?

by Children's Hospital BostonCredit: CC0 Public DomainOur immune system makes interferons and other cytokines to help us fight viruses. But in COVID-19, we've learned that they can also c

Updated on:April 16,2024 15

Clinical Pearl Series:Special Viral Infection by Coronaviruses

Updated on: April 13,2024 0

Clinical Pearl Series:Special Viral Infection by Coronaviruses

Updated on:April 13,2024 0

COVID-19: Anti-viral strategy with double effect

by Brigitte Holfelder,Max Planck SocietyThe protease PLpro of Sars-CoV-2 plays a central role in the viral life cycle. By cleaving also proteins of infected cells, PLpro interferes with the inna

Updated on: April 12,2024 17

COVID-19: Anti-viral strategy with double effect

by Brigitte Holfelder,Max Planck SocietyThe protease PLpro of Sars-CoV-2 plays a central role in the viral life cycle. By cleaving also proteins of infected cells, PLpro interferes with the inna

Updated on:April 12,2024 17